Interestingly, it has been reported that VDAC inhibitors can restore insulin secretion in type 2 diabetes islet donors and prevent hyperglycemia in diabetic mice (Zhang et al., 2019). This evidence concerns the gene VDAC1 and type 2 diabetes mellitus.